| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 115, 951-958, Copyright © 1984 by Endocrine Society
ARTICLES |
SB Rodan, MK Fischer, JJ Egan, PM Epstein and GA Rodan
Treatment of ROS 17/2.8 osteosarcoma-derived cells with dexamethasone potentiates the PTH stimulation of adenylate cyclase in these cells, yielding a detectable response to as little as 10 pM PTH. Isoproterenol stimulation was also enhanced. The dexamethasone effect is first apparent at 12 h and increases with time of treatment. The apparent EC50 for dexamethasone is 3 nM. Hydrocortisone and corticosterone act similarly to dexamethasone, but require 30-fold higher concentrations. Dexamethasone treatment produces no change in high affinity phosphodiesterase activity. Glucocorticoid-potentiating effects are much more pronounced in whole cells than in broken cells and do not influence forskolin stimulation. Particulate fractions of dexamethasone- treated cells have higher adenylate cyclase specific activity, but are stimulated by guanyl-5'-yl imidodiphosphate to the same extent as control cells. These findings suggest that the glucocorticoids potentiate hormone responsiveness through promotion of hormone receptor- adenylate cyclase coupling by a mechanism dependent on cellular integrity.
This article has been cited by other articles:
![]() |
M. Homme, C. P. Schmitt, R. Himmele, G. F. Hoffmann, O. Mehls, and F. Schaefer Vitamin D and Dexamethasone Inversely Regulate Parathyroid Hormone-Induced Regulator of G Protein Signaling-2 Expression in Osteoblast-Like Cells Endocrinology, June 1, 2003; 144(6): 2496 - 2504. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Rubin and J. P. Bilezikian The Role of Parathyroid Hormone in the Pathogenesis of Glucocorticoid-Induced Osteoporosis: A Re-Examination of the Evidence J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4033 - 4041. [Full Text] [PDF] |
||||
![]() |
L. Nguyen-Yamamoto, L. Rousseau, J.-H. Brossard, R. Lepage, and P. Damour Synthetic Carboxyl-Terminal Fragments of Parathyroid Hormone (PTH) Decrease Ionized Calcium Concentration in Rats by Acting on a Receptor Different from the PTH/PTH-Related Peptide Receptor Endocrinology, April 1, 2001; 142(4): 1386 - 1392. [Abstract] [Full Text] |
||||
![]() |
T. L. McCarthy, C. Ji, Y. Chen, K. Kim, and M. Centrella Time- and Dose-Related Interactions between Glucocorticoid and Cyclic Adenosine 3',5'-Monophosphate on CCAAT/Enhancer-Binding Protein-Dependent Insulin-Like Growth Factor I Expression by Osteoblasts Endocrinology, January 1, 2000; 141(1): 127 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Mori, A. Shioi, S. Jono, Y. Nishizawa, and H. Morii Dexamethasone Enhances In Vitro Vascular Calcification by Promoting Osteoblastic Differentiation of Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., September 1, 1999; 19(9): 2112 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Merendino Jr, K. Insogna, L. Milstone, A. Broadus, and A. Stewart A parathyroid hormone-like protein from cultured human keratinocytes Science, January 24, 1986; 231(4736): 388 - 390. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |